ARCHIVES

Obama Administration, WellPoint, Face Off Over Allegation Of Coverage Recissions

This article is from The Cancer Letter archive.

Vol. 36 No. 16 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

August 30, 2013

Biomarker Identified Predicting Graft-Versus-Host Disease Risk

August 30, 2013

Separation Will Make Interaction Easier; AACR President Says

June 26, 1992

The March To Deliver Message Of Funding For Cancer Research, Access To Care

September 4, 1998

Adriamycin Update Discussed At Seminar

January 10, 1975

Seer Places Survival Now at Least At 45 Percent, Could Be As High As 50 Percent For 1973-79 Patients

December 4, 1981